Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-086607
Filing Date
2021-06-29
Accepted
2021-06-29 09:48:30
Documents
2
Period of Report
2021-06-28

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2120917-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2120917-1_4seq1.xml 4 42653
2 EXHIBIT 24 tm2120917d1_ex24.htm EX-24 8133
  Complete submission text file 0001104659-21-086607.txt   52247
Mailing Address C/O ATLAS VENTURE 890 WINTER STREET WALTHAM MA 02451
Business Address
FORMELA JEAN FRANCOIS (Reporting) CIK: 0001030575 (see all company filings)

State of Incorp.: MA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37766 | Film No.: 211056057

Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Issuer) CIK: 0001652130 (see all company filings)

EIN.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances